Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) SHH
47.59
-0.81(-1.67%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
47.59
-0.81(-1.67%)
Currency In CNY
Address
38 Huanghe Rd Eco & Tech Dev Park
Lianyungang, 222000
China
Phone
86 518 8122 0983
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
20238
First IPO Date
October 18, 2000
| Name | Title | Pay | Year Born |
| Lian Shan Zhang | Executive Vice President & Executive Director | 0 | 1962 |
| Ningjun Jiang | Executive Vice President, Chief Strategy Officer & Executive Director | 0 | 1961 |
| Cheng Liao | Deputy General Manager | 0 | 1976 |
| Feng He | Deputy General Manager | 0 | 1967 |
| Ya Ping Shen | Deputy General Manager | 0 | 1964 |
| Hong Bin Dai | Executive Deputy Chairman of the Board | 0 | 1976 |
| Jie Ping Sun | Senior Vice President & Executive Director | 0 | 1970 |
| Kin Chun Lau | Chief Financial Officer | 0 | 1979 |
| Piao Yang Sun | Executive Chairman of the Board | 0 | 1958 |
| Xiao Han Liu | Board Secretary | 0 | 1985 |
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.